Rhythmm AI cuts the prior authorization wait time from days to seconds. Our AI platform eliminates the number one cause of treatment delays, helping Physicians deliver care faster while reducing costs for all involved.
Rhythmm AI cuts the prior authorization wait time from days to seconds. Our AI platform eliminates the number one cause of treatment delays, helping Physicians deliver care faster while reducing costs for all involved.
The current prior authorization process in utilization review is manual, labor-intensive, and error-prone, resulting in substantial hardships for medical management companies, payers, employers, and patients. The inefficiencies lead to approval and denial delays, lack of real-time visibility, higher administrative costs, and an inability to prioritize critical patient needs or identify optimal treatment options. The absence of interoperability prevents steerage companies from proactively finding cost-effective services, while the fragmented and opaque process adversely impacts productivity, expenses, and patient outcomes, necessitating streamlining through automation and transparency for systemic improvement.
Since our soft launch in January 2024, Rhythmm AI has secured contracts worth $3.2M from Third Party Administrators and national Health Plans serving the group employer space. After full implementation in May 2024, we've achieved $165K in ARR with consistent 16.3% month-over-month growth. Our rapid adoption demonstrates a strong product-market fit in the healthcare payer space.
